A researcher is planning on investigating potential treatments aimed at the root causes of type 1 diabetes. At the (MUSC), ...

U.S. pharmaceutical company Eli Lilly plans to disclose the topline results of its phase 3 clinical trial for “remternutux,” a new drug candidate developed as a successor to its Alzheimer’s treatment ...

A bill that would allow executions by firing squad if lethal injection drugs are unavailable or at an inmate’s request is ...

Altcoins are quietly absorbing liquidity while Bitcoin struggles to hold its share. As smaller tokens capture more volume, it ...

Johnson & Johnson today announced new longer follow-up results from the investigational Phase 1b/2 OrigAMI-1 study evaluating amivantamab-vmjw, a bispecific antibody targeting epidermal growth factor ...